According to the National Cancer Institute, the cost of cancer care will reach $246B in 2030. NurLabs is transforming the diagnosis and treatment paradigm for cancer through a patented liquid biopsy platform, so we may treat cancer earlier, when survival rates are the greatest and treatment is the least expensive. Our innovation is the nexus of materials science and bioinformatics, bringing a fresh perspective to a $246B problem.